Cargando…
Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier
BACKGROUND: The presence of calcitonin gene-related peptide and its receptors in multiple brain areas and peripheral tissues previously implicated in migraine initiation and its many associated symptoms raises the possibility that humanized monoclonal anti-calcitonin gene-related peptide antibodies...
Autores principales: | Noseda, Rodrigo, Schain, Aaron J, Melo-Carrillo, Agustin, Tien, Jason, Stratton, Jennifer, Mai, Fanny, Strassman, Andrew M, Burstein, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233263/ https://www.ncbi.nlm.nih.gov/pubmed/31856583 http://dx.doi.org/10.1177/0333102419896760 |
Ejemplares similares
-
Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats
por: Melo-Carrillo, Agustin, et al.
Publicado: (2019) -
The Anti-CGRP Antibody Fremanezumab Lowers CGRP Release from Rat Dura Mater and Meningeal Blood Flow
por: Dux, Mária, et al.
Publicado: (2022) -
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons
por: Melo-Carrillo, Agustin, et al.
Publicado: (2020) -
OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier
por: Melo-Carrillo, Agustin, et al.
Publicado: (2021) -
DNA Evidence Uncompromised by Active Oxygen
por: Castelló, Ana, et al.
Publicado: (2010)